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Abstract: Introduction: Infective endocarditis (IE) is a very heterogeneous condition for several reasons. The diagnosis 
can be notoriously difficult. A delay in diagnosis can have severe consequences. Even proper application of the Duke 
criteria cannot solve all cases. For this reason, positron emission tomography / computer tomography (PET/CT) with 
18F-fluorodesoxyglucose (18FDG) has been proposed in the 2015 guidelines of the European Society of Cardiology. 
What has been the effect of these guidelines thus far? 
Methods: A probe of the literature has been performed in PubMed, from 2016 on using the search terms “endocarditis 
AND PET” 
Results: One hundred items were identified, of which 41 documents could be retained. However, only 16 were original 
series, mostly with low numbers. The other manuscripts were editorials, comments, reviews and “image vignettes”. 
PET/CT increased the sensitivity of the Duke criteria in cases of prosthetic valve endocarditis (PVE), but in a much 
lesser degree in native valve endocarditis (NVE). Patient preparation should be standardized in order to reduce the 
uptake of 18FDG by the myocardium. This includes low carbohydrate – high fat diet, fasting and unfractionated heparin 
administration. Furthermore, image acquisition and processing (quantification, correction for attenuation, taking into 
account implanted metallic materials) should also be standardized. Effects of antibiotics (negative imaging results before 
cure) and inflammation (especially healing after operation and use of biological glue materials) should be taken into 
account. Radiolabeled white blood cell scintigraphy could be a valuable adjunct in these cases. The detection of extra-
cardiac foci (especially tumors which can serve as port of entry and septic emboli) is an additional advantage.  
Conclusion: PET/CT seems a valuable tool to increase the accuracy in diagnosing IE, especially PVE. Early 
postoperative cases must be interpreted with caution. To confirm the value of PET/CT, the major centers should 
standardize their method. This allows comparison of results of larger patient groups, which could be collected in the 
International Collaboration of Endocarditis – Prospective Cohort Study. Nuclear cardiologists should also be included in 
“endocarditis teams.  
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INTRODUCTION 
Infective endocarditis (IE) is a very heterogeneous 
condition. Well-known variables are the causative 
agents, the site and severity of the infection. The latter 
includes presence or absence of paravalvular 
involvement, abscesses, fistulae, chordal rupture, valve 
perforation and heart block as sign of intra-cardiac 
destruction. This can lead to congestive heart failure, 
which is one of the strongest predictors of poor 
outcome [1]. Other variables are the effect on other 
organs through septic emboli. This can lead to 
devastating complications such as stroke but can also 
remain silent. Last but not least, IE can occur as native 
valve endocarditis (NVE) or after the implantation of 
prosthetic valves, prosthetic valve endocarditis (PVE) 
or electronic cardiac devices cardiac device related IE 
(CDRIE). The outcome of IE depends highly on timely 
and adequate intervention and can be influenced by 
other factors such as referral and treatment bias [1]. 
 
 
*Address correspondence to this author at the Division of Physiotherapy, 
Faculty of Medicine and Health Sciences, University of Antwerp, Campus Drie, 
Eiken, Universiteitsplein 1, 2610 Antwerp, Belgium;  
Tel: 32 3 265 27 82; Fax: 32 3 265 51 20;  
E-mail: wilhelm.mistiaen@ap.be; wilhelm.mistiaen@uantwerpen.be 
The diagnosis of IE can be notoriously difficult. The 
ESC added in their guidelines the need for an 
“endocarditis team” and suggested also the use of 
nuclear imaging [2]. Positron emission tomography 
(PET) with 18-fluoro-desoxyglucose (18-FDG) as 
marker for increased metabolism can serve such as in 
inflammation, infection and malignancies [3]. Another 
method is labeling of white blood cells (WBC)] with a 
radionuclide tracer which is considered as more 
specific for infection [4]. The question to answered is in 
how far these guidelines had already an effect on 
management of IE. 
METHODS 
A small screening probe through PubMED from 
2016 to 2018 was performed using the search terms 
“endocarditis AND PET”. Case studies, congenital 
heart defects and no free access manuscripts were 
excluded. Included were all papers (original articles, 
reviews, meta-analyses, editorials, technical 
comments) dealing with native IE (NVE), prosthetic 
valve IE (PVE) and cardiac electronic device related IE 
(CDRIE). 
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RESULTS 
With these search terms, one hundred items were 
found. Forty-one documents could be retained. Of 
these, only 16 were original articles. There were 9 
reviews, 7 editorials, two meta-analyses and 7 
manuscripts of another type. The original articles are 
listed in Table 1. Most of them are smaller series: 
eleven articles have less than 100 patients, five of them 
are larger. Most of them are retrospective and 
observational and are aimed to assess the added value 
of PET/CT scan. One paper does not focus on IE but 
on the uptake pattern after valve replacement [5]. 
Nevertheless, this paper has been included because 
this offers valuable information about interpreting 
Table 1:  The Original Series  
Author n  Type  Aim Conclusion  
Amrawi 2016 [35] 35 CDRIE Search for septic embolism emboli in 10/35 (sometimes clinically silent or not visible on CT) 
Fagman 2016 [19] 27 8 PVE 19 controls retr. cc. 
comparison with non-infected 
valve prostheses AUC = 0.90 








evaluate diagnostic accuracy 
of PET/CT in suspected IE 
limited value in NE PET-CT is a valuable 
adjunct for doubtful cases other foci and 
neoplasms 
Jimenez-Ballvé 2016 
[18] 41 PVE/ CDRIE 
usefulness of PET/CT 
interpretation criteria 
AUC = 0.71 importance of patient 
preparation 
Salomaki 2016 [7] 23 PVE 16 NVE 7 search for paravalv. infection PET/CT sensitive in PVE but limited value in NVE 
Kokalova 2017 [36] 13 PVE evaluation of PET high spec, sens. and PPV low NPV; reveals extra cardiac foci 
Kouijzer 2017 [38] 273 Q-fever diagnostic value of PET/CT PET/CT provides important diagnostic and prognostic information in Q fever 
Machelart 2017 [31] 10 Bentall graft infection use of PET/CT during follow-up impact of PET on clinical management is unclear 




features of PET/CT uptake 
pattern 
often homogenous 
mild-to-moderate tracer accumulation 
Pizzi 2017 [39] 25 
cong. HD with 
prosthesis 
prospective 
value PET/CTA in complex 
anatomy 
Duke criteria are low sens. and NPV; 
PET/CTA improves these with accuracy 
Scholtens 2017 [27] 13 PVE 60’ v. 150’ imaging improves accuracy? late imaging is prone to false +: caution! 





effect of SBC for S. aureus 
bacteremia PET and TEE have added value 
Diemberger 2018 [6] 105 CDRIE, prosp. obs. evaluate extended CDIE by PET/CT on survival 
survival improves by correct identification 
CDRIE by PET/CT 
Gomes 2018 [40] 176 obs. NVE, PVE & CDRIE 
comparing echo, CTA & 
PET/CT 
modalities are complementary for these 
conditions 
kouijzer 2018 [14] 88 NVE retrosp. value of PET/CT negative PET/CT does not exclude NVE useful for extra-cardiac 





improving accuracy & 
performance; excluding conf. 
low inflammatory activity (prolonged 
antibiotic) is a confounder 
Abbreviations: cc. case control; CDRIE: cardiac device related infective endocarditis; conf.: confounders; cong. HD: congenital heart disease; 
echo: echocardiography NVE: native valve endocarditis; NPV: negative predictive value; obs.: observational; paravalv.: paravalvular; PET/CT: 
positron emission tomography / computer tomography; PPV: positive predictive value; prosp.: prospective; PVE: prosthetic valve endocarditis; 
retr.: retrospective; SBC: structured bedside consultation; sens.: sensitivity; spec.: specificity; SUV: standard uptake value; TBR: target-to-
background-ratio; TEE: transesophageal echocardiography. 
* indication for PET/CT: oncologic, suspected but at hindsight excluded PVE, vasculitis. 
NOTE: TBR = SUV max valve / SUV mean blood pool. 
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postoperative PET/CT images. Several issues are 
addressed for this interesting imaging modality.  
Increase in Accuracy by PET/CT 
Most important is the added value of PET/CT in 
different types of IE (NVE, PVE and CDRIE). The 
reason is the numbers of false positive and false 
negatives of the Duke criteria for IE. Late recognition of 
this condition can lead to increased mortality. Correct 
identification improves survival in patients with 
electronic cardiac implants and IE [6]. PET/CT leads to 
an increased sensitivity, especially in patients with PVE 
[7-13]. Adding PET/CT could increase the sensitivity of 
the modified Duke criteria to about 90%. A negative 
PET/CT does not exclude the presence of NVE [14] 
because its sensitivity is low [4]. The reason could be 
the low number of inflammatory cells in vegetation in 
NVE [4]. PVE is associated with perivalvular 
involvement and tissue destruction and clearly has an 
added value for pseudo-aneurysms and abscesses 
[11]. With PET/CT, up to 90% of the undecided cases 
of PVE could be reclassified [15] and misdiagnosis can 
be reduced [16]. These methods should not replace the 
more classic imaging techniques but should be 
integrated into decision algorithms [15, 17]. Using 
PET/CT could increase the area under the curve in the 
receiver-operator-curve analysis to 0.71 [18] and even 
0.90 [19, 20] in PVE. Prolonged antibiotic treatment in 
patients with PVE, however, leads to lowered 
inflammatory activity, which could serve as a 
confounder [21]. In cases of doubt, PET/CT could be 
complemented with WBC scintigraphy [4]. It is also 
important to keep in mind that echocardiography or 
cardiac CT is needed to document vegetation in PVE 
[2, 11].  
Patient Preparation 
The use of 18-FDG is based on metabolic trapping 
of this radiolabeled agent since it cannot be further 
processed. This is more outspoken in metabolic active 
tissues. In physiologic conditions, this is for example 
the myocardium. For this reason, patient preparation is 
needed. This includes a low carbohydrate – high fat 
diet, and administration of unfractionated heparin, to 
suppress the myocardial 18-FDG uptake [16, 18, 22, 
23]. The image processing should make use of the 
maximum standard uptake value (SUV-max) and of 
target to background ratio (TBR), taking into account 
both parameters show a great variability of overlap 
between patients with and without PVE. Cut-off values 
at 4.4 [24] or lower [21] have been proposed. 
Correction of attenuation [25] should be performed and 
the proximity of metallic prosthetic material, if present, 
should be taken into account. The timing of imaging-
taking is considered as useful [2, 26, 27], but not by all 
[24]. 
Inflammation V. Infection  
Infection and inflammation of other causes such as 
postoperative healing and foreign body reaction should 
be discerned because of their different management 
and outcome. Scintigraphic techniques, based on 
radiolabeled WBC can serve as complement for 
distinction between sterile inflammation and infection 
[4, 15, 25, 28]. Although PET/CT has the advantage of 
detecting cells with high metabolic activity and has a 
short acquisition time, the technique does not 
distinguish inflammation from infection. IE is more 
probable in presence of an intense and focal 
perivalvular uptake of 18-FDG but biological surgical 
glues and suture material [25, 29] can also produce this 
effect. Sterile postoperative inflammation at the border 
between the host tissue and prosthetic material can 
exists for some months in an animal model [26], and 
sometimes even for years on PET/CT imaging [25]. 
Moreover, without proper preparation, the adjacent 
myocardium also shows a high uptake [4]. 
Nevertheless, PET/CT allows a reclassification of 
possible IE into definitive IE or rejection of the 
diagnosis [4]. Radiolabeled WBC accumulate in areas 
of bacterial infection such as IE and shows high 
sensitivity (up to 90%) and a 100% specificity. These 
inflammatory cells are absent in vegetation, which are 
usually small [4]. WBC scintigraphy has the 
disadvantage of handling blood products in-vitro and a 
longer preparation time. As for PET/CT, WBC 
scintigraphy can also detect metastatic infections due 
to septic emboli [28]. This is important in postoperative 
situations where early PVE is suspected. One series 
studied non-infected prosthetic valves [5] thereby 
providing useful imaging data: inflammation as part of a 
healing process often shows a homogenous, mild-to-
moderate and steady accumulation of the tracer [29]. 
This can be important in situations with suspected early 
PVE in the first weeks after valve replacement. Waiting 
to perform PET/CT does not solve the problem of false 
positive imaging, hence there is no reason to wait 
according to some authors [26], but not to others [29]. 
However, on the one hand, one should be aware for 
suture material [29], and surgical adhesive material  
[2, 13, 25, 29], which show more intense accumulation. 
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On the other hand, the level of inflammation in true IE 
can be lowered by prolonged use of antibiotics [21, 30], 
which can result in false negative results on PET/CT. 
Moreover, it is not clear if PET/CT can be used to 
assess the effect of antibiotics [15]. Especially in early 
postoperative PVE, foreign body reaction and a low 
degree of inflammation due to antibiotic treatment are 
not always easy to distinguish [4, 24]. In certain 
conditions, such as infection of a Bentall graft, the 
added value of PET/CT is unclear [31]. Remission of 
“hot spots” does not equal cure of IE [2]. Some other 
sources might cause false interpretation. One of the 
more known anomalies is lipomatous interatrial 
hypertrophy [2, 24, 32]. Correlation of these metabolic 
data with anatomical findings in CT such as abscesses, 
fistulae, pseudo-aneurysms and thickening of leaflets, 
and vegetation is invaluable in the distinction of IE [29]. 
Extra-Cardiac Foci  
One of the extra bonuses of PET/CT are the extra-
cardiac foci. These included the possible mechanisms 
of development of IE. Malignancies, especially those of 
the digestive tract could serve as port of entry for 
bacteria [33, 34] such as streptococcus gallolyticus and 
enterococci. The included original series [9, 14, 35, 36] 
also mention the detection of extra-cardiac 
manifestations of the disease. Even in patients without 
clinical suspicion, up to 65%of the cases show such 
possible emboli [37]. In a meta-analysis, this has been 
17% [12]. The use of PET/CT is especially useful for 
those patients in whom an MRI is not possible because 
of a previously implanted cardiac electronic device  
[15, 30].  
CONCLUSIONS 
PET/CT is a useful imaging method for inflamma- 
tory cardiovascular conditions and it complements 
more conventional imaging methods [11]. PET/CT 
shows the combined metabolic and anatomical data. 
Still, in the last years only a few large series of over 
100 patients have been published; most series are 
small, observational and retrospective and therefore 
prone to bias (3). Randomized controlled trials are 
difficult to design for ethical reasons. Larger multicenter 
based series over some expanded time are needed, in 
order to collect enough data. A standardized method 
for patient preparation, imaging acquisition and 
processing is needed. This can best be undertaken 
through the International Collaboration on Endocarditis 
– Prospective Control Study ICE-PCS. Pitfalls such as 
inflammatory repair in the early postoperative period 
and low inflammation – without cure – after prolonged 
antibiotic treatment can lead to misinterpretations. 
Moreover, the method is useful in patients with PVE, 
but much less with NVE.  
It was also remarkable to see more reviews, 
editorials and comments of several types compared to 
original series between 2016 and 2018. This stresses 
even more the need for prospective multicenter 
collection of data over an extended period. Only two 
larger series could be identified. One series showed 
the value of the structured bedside consult in cases of 
bacteremia with S. aureus [37] and also showed the 
value of PET/CT, even in patients with suspected PVE 
in the early postoperative course. Standardization of 
every step in the PET/CT protocol is mandatory. The 
method can be incorporated in decision algorithms for 
NVE and PVE separately [15, 17], by specially 
assigned “endocarditis teams” [4]. 
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